If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mariateresa Lapresa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Drug Therapy Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
Retrospective Studies Medicine & Life Sciences
Hysterectomy Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Carboplatin
Endometrial Neoplasms
Paclitaxel
Disease-Free Survival
Combination Drug Therapy

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Carboplatin
Endometrial Neoplasms
Paclitaxel
Disease-Free Survival
Combination Drug Therapy

Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study

Gadducci, A., Landoni, F., Cosio, S., Zizioli, V., Zola, P., Ferrero, A. M., Lapresa, M. T., Maggino, T. & Sartori, E., Jun 2018, In : Anticancer Research. 38, 6, p. 3627-3634 8 p.

Research output: Contribution to journalArticle

Platinum
Hysterectomy
Cervix Uteri
Multicenter Studies
Adenocarcinoma

Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: A single institution prospective series

Ricciardi, E., Tomao, F., Aletti, G., Bazzurini, L., Bocciolone, L., Boveri, S., Landoni, F., Lapresa, M. T., Maruccio, M., Parma, G., Peccatori, F., Petrella, M. C., Zanagnolo, V., Colombo, N. & Maggioni, A., Sep 1 2017, In : Anticancer Research. 37, 9, p. 5241-5248 8 p.

Research output: Contribution to journalArticle

Ovariectomy
Ovarian Neoplasms
Breast Neoplasms
Carcinoma in Situ
Neoplasms

Neoadjuvant chemotherapy in cervical cancer: An update

Lapresa, M., Parma, G., Portuesi, R. & Colombo, N., Oct 3 2015, In : Expert Review of Anticancer Therapy. 15, 10, p. 1171-1181 11 p.

Research output: Contribution to journalArticle

Uterine Cervical Neoplasms
Drug Therapy
Meta-Analysis
Risk Reduction Behavior
Paclitaxel